GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
L

Luyan Pharma Co 002788.SZ · CNY

Health Care · Shenzhen · 🇨🇳 China

Compare

9.36

-1.78%

Close of 9 Nov 2026, in CNY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Luyan Pharma Co

Its shares trade on Shenzhen under the ticker 002788.SZ. It has been listed since 18 February 2016. In the fiscal year to 31 December 2025, it reported revenue of CN¥21.25bn and net income of CN¥280.9m. At that date it held total assets of CN¥13.40bn and shareholders' equity of CN¥3.31bn.

Luyan Pharma Co., Ltd. wholesales, markets, distributes, manufactures, and retails pharmaceuticals, medical equipment and healthcare products. The company is headquartered in Xiamen, Fujian. The company went IPO on 2016-02-18. The firm makes Fujian Province as its major target market and provides its products directly to medical institutions at all levels.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Health Care Providers & Services
Listed since
18 Feb 2016
Employees
5,286

Leadership

Pay as last reported

  • Mr. Jinxiang WuChairman of the Board, General Manager
  • Mr. Di WuVice Chairman of the Board, Deputy General Manager
  • Ms. Zheng ZengChief Financial Officer
  • Mr. Ming LeiChief Compliance Officer, Deputy General Manager, Director, since 2023
  • Mr. Weiyang LiDeputy General Manager
  • Mr. Jin LiuDeputy General Manager
  • Ms. Junying ZhangDeputy General Manager
  • Mr. Mingguo ZhuDeputy General Manager, since 2023
  • Mr. Quanqing YeSecretary of the Board
  • Mr. Qizhuan XuDirector
  • Mr. Peilin SongIndependent Director
  • Mr. Junlong WuIndependent Director

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Luyan Pharma targets Fujian Province as its major market with 5,286 employees.
  • The company wholesales and distributes pharmaceuticals directly to medical institutions nationwide.
  • Luyan Pharma's IPO in 2016 established a strong market presence in Health Care.

Weaknesses

  • Luyan Pharma's operations are concentrated in Fujian Province limiting broader market reach.
  • The company relies heavily on direct sales to medical institutions without diversifying channels.
  • Luyan Pharma has no international presence beyond China's domestic market.

Opportunities

  • Expanding into neighboring provinces could increase market share in China's Health Care sector.
  • Growing demand for medical equipment in China presents new business opportunities.
  • Luyan Pharma can leverage its 5,286 employees to enhance product distribution networks.

Threats

  • Fujian Province's market saturation may reduce growth potential for Luyan Pharma.
  • Regulatory changes in China's Health Care industry could impact operations.
  • Competition from other domestic pharmaceutical firms in Fujian Province is increasing.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.